Entrada Therapeutics
TRDA
TRDA
97 hedge funds and large institutions have $481M invested in Entrada Therapeutics in 2024 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 42 increasing their positions, 18 reducing their positions, and 8 closing their positions.
Holders
97
Holders Change
+14
Holders Change %
+16.87%
% of All Funds
1.4%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
22
Increased
42
Reduced
18
Closed
8
Calls
$551K
Puts
$262K
Net Calls
+$289K
Net Calls Change
+$288K
Top Buyers
| 1 |
1
Janus Henderson Group
London,
United Kingdom
|
$27.4M |
| 2 |
2
BlackRock
New York
|
$29.1M |
| 3 |
3
Dimensional Fund Advisors
Austin,
Texas
|
$1.53M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$19.5M |
| 5 |
5
Arrowstreet Capital
Boston,
Massachusetts
|
$1.59M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
Man Group
London,
United Kingdom
| – | – | -17,249 | Closed |
|
102
Walleye Capital
New York
| – | – | -13,323 | Closed |
|
|
CIC
103
Cornercap Investment Counsel
Atlanta,
Georgia
| – | – | -13,014 | Closed |
|
|
PIM
104
Plato Investment Management
Sydney, NSW,
Australia
| – | – | -61 | Closed |
|
|
AACP
105
Advantage Alpha Capital Partners
San Francisco,
California
| – | – | -20 | Closed |
|
|
CFGS
106
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
107
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | – | – | – |
|